Catalent
CTLT
#1737
Rank
โ‚ฌ9.89 B
Marketcap
54,52ย โ‚ฌ
Share price
0.00%
Change (1 day)
3.45%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total debt

Total debt on the balance sheet as of September 2024 : โ‚ฌ4.24 Billion

According to Catalent's latest financial reports the company's total debt is โ‚ฌ4.24 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Catalent - Total debt on balance sheet (from 2013 to 2024)

Total debt by year

Year Total debt Change
2023-06-30โ‚ฌ4.45 B10.66%
2022-06-30โ‚ฌ4.02 B46.48%
2021-06-30โ‚ฌ2.74 B1.76%
2020-06-30โ‚ฌ2.69 B3.67%
2019-06-30โ‚ฌ2.60 B11.99%
2018-06-30โ‚ฌ2.32 B27.58%
2017-06-30โ‚ฌ1.82 B8.8%
2016-06-30โ‚ฌ1.67 B-0.82%
2015-06-30โ‚ฌ1.68 B-14.67%
2014-06-30โ‚ฌ1.97 B-4.29%
2013-06-30โ‚ฌ2.06 B-2.44%
2012-06-30โ‚ฌ2.11 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Supernus Pharmaceuticals
SUPN
โ‚ฌ36.25 M-99.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
โ‚ฌ0.28 B-93.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
โ‚ฌ4.66 B 9.73%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
โ‚ฌ0.19 B-95.47%๐Ÿ‡บ๐Ÿ‡ธ USA